<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id><journal-title>BMC Public Health</journal-title><issn pub-type="epub">1471-2458</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16848888</article-id><article-id pub-id-type="pmc">1550238</article-id><article-id pub-id-type="publisher-id">1471-2458-6-186</article-id><article-id pub-id-type="doi">10.1186/1471-2458-6-186</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Prevention of anxiety and depression in the age group of 75 years and over: a randomised controlled trial testing the feasibility and effectiveness of a generic stepped care programme among elderly community residents at high risk of developing anxiety and depression versus usual care [ISRCTN26474556]</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>van 't Veer-Tazelaar</surname><given-names>Nelleke</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>pj.vantveer@vumc.nl</email></contrib><contrib id="A2" contrib-type="author"><name><surname>van Marwijk</surname><given-names>Harm</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>hwj.vanmarwijk@vumc.nl</email></contrib><contrib id="A3" contrib-type="author"><name><surname>van Oppen</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>pvanoppen@ggzba.nl</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Nijpels</surname><given-names>Giel</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>g.nijpels@vumc.nl</email></contrib><contrib id="A5" contrib-type="author"><name><surname>van Hout</surname><given-names>Hein</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>hpj.vanhout@vumc.nl</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Cuijpers</surname><given-names>Pim</given-names></name><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><email>p.cuijpers@psy.vu.nl</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Stalman</surname><given-names>Wim</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>w.stalman@vumc.nl</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Beekman</surname><given-names>Aartjan</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>aartjanb@ggzba.nl</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of General Practice, VU University Medical Centre, Amsterdam, The Netherlands</aff><aff id="I2"><label>2</label>Institute for Research in Extramural Medicine, VU University Medical Centre, Amsterdam, The Netherlands</aff><aff id="I3"><label>3</label>Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands</aff><aff id="I4"><label>4</label>Department of Clinical Psychology, VU University Medical Centre, Amsterdam, The Netherlands</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>18</day><month>7</month><year>2006</year></pub-date><volume>6</volume><fpage>186</fpage><lpage>186</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2458/6/186"></ext-link><history><date date-type="received"><day>7</day><month>6</month><year>2006</year></date><date date-type="accepted"><day>18</day><month>7</month><year>2006</year></date></history><permissions><copyright-statement>Copyright Â© 2006 van 't Veer-Tazelaar et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>van 't Veer-Tazelaar et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="4802" xml_f="4812" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4823" xml_f="5293" txt_i="22" txt_f="492">In frail elderly, the effects of depression and anxiety are deep encroaching. Indicated prevention studies, aimed at subjects with subthreshold disorder, have shown that well designed interventions are capable of reducing the incidence of depression and anxiety. In this randomised prevention trial for elderly, living in the community and suffering from subthreshold depression and anxiety, a stepped care programme was put together to be tested versus usual (GP) care.</offsets></p></sec><sec><title><offsets xml_i="5315" xml_f="5329" txt_i="494" txt_f="508">Methods/design</offsets></title><p><offsets xml_i="5340" xml_f="5376" txt_i="509" txt_f="545">Design: randomised controlled trial.</offsets></p><p><offsets xml_i="5383" xml_f="5384" txt_i="546" txt_f="547">(</offsets><italic><offsets xml_i="5392" xml_f="5396" txt_i="547" txt_f="551">See </offsets></italic><offsets xml_i="5405" xml_f="5412" txt_i="551" txt_f="558">figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="5442" xml_f="5443" txt_i="558" txt_f="559">1</offsets></xref><offsets xml_i="5450" xml_f="5452" txt_i="559" txt_f="561">: </offsets><italic><offsets xml_i="5460" xml_f="5478" txt_i="561" txt_f="579">organisation chart</offsets></italic><offsets xml_i="5487" xml_f="5793" txt_i="579" txt_f="885">) together with two other projects, this project is part of a national consortium that investigates the prevention of anxiety and depressive disorders in later life using a stepped care programme. The three projects have their own particular focus. This project is aimed at elderly living in the community.</offsets></p><p><offsets xml_i="5800" xml_f="6385" txt_i="886" txt_f="1471">Inclusion: subjects with a high risk for depression and anxiety without clinical evidence of these syndromes. The participants are 75 years of age and over and have subthreshold symptoms of depression and or anxiety: they score above the cut-off point on the self-report Centre for Epidemiologic Studies Depression (CES-D) scale, but the criteria for a major depressive disorder or anxiety disorder (panic disorder, agoraphobia, social phobia, generalized anxiety disorder) according to a validated interview, the Mini International Neuropsychiatric Interview (MINI) are not fulfilled.</offsets></p><p><offsets xml_i="6392" xml_f="6401" txt_i="1472" txt_f="1481">Outcomes:</offsets></p><p><offsets xml_i="6408" xml_f="6505" txt_i="1482" txt_f="1579">primary outcome: incidence of a depressive or anxiety disorder over a period of two years (MINI);</offsets></p><p><offsets xml_i="6512" xml_f="6784" txt_i="1580" txt_f="1852">secondary outcome: a positive influence of the intervention, a stepped care programme, on symptoms of depression and anxiety and on quality of life as assessed with the CES D, the HADS A and the SF36 respectively (i.e. stabilisation or improvement of symptoms) [see table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="6816" xml_f="6817" txt_i="1852" txt_f="1853">1</offsets></xref><offsets xml_i="6824" xml_f="6826" txt_i="1853" txt_f="1855">].</offsets></p><p><offsets xml_i="6833" xml_f="6846" txt_i="1856" txt_f="1869">Measurements:</offsets></p><p><offsets xml_i="6853" xml_f="7039" txt_i="1870" txt_f="2056">Take place at baseline and at 3, 6, 9, 12, 18 and 24 months. Trained independent evaluators assess depression and anxiety status, the primary end point (6, 12, 18, 24 months) [see table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="7071" xml_f="7072" txt_i="2056" txt_f="2057">2</offsets></xref><offsets xml_i="7079" xml_f="7081" txt_i="2057" txt_f="2059">].</offsets></p></sec><sec><title><offsets xml_i="7103" xml_f="7113" txt_i="2061" txt_f="2071">Discussion</offsets></title><p><offsets xml_i="7124" xml_f="7504" txt_i="2072" txt_f="2452">Late-life depression and anxiety are characterised by high prevalence, unfavourable prognosis, reduced quality of life, excess mortality and substantial societal costs. No health service, however well equipped, will be able to effectively treat all elderly with depression and anxiety. Therefore, development of (cost) effective means to prevent these disorders is very important.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="7566" xml_f="7576" txt_i="2461" txt_f="2471">Background</offsets></title><p><offsets xml_i="7587" xml_f="7943" txt_i="2472" txt_f="2828">Depression and anxiety lead to a serious impairment of daily functioning and quality of life. In frail elderly, the effects of depression and anxiety are especially deep encroaching. Besides a deleterious effect on daily functioning and quality of life, a large number of studies demonstrate excess mortality, disability, handicap and service utilisation [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="7974" xml_f="7975" txt_i="2828" txt_f="2829">1</offsets></xref><offsets xml_i="7982" xml_f="7983" txt_i="2829" txt_f="2830">-</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="8014" xml_f="8015" txt_i="2830" txt_f="2831">7</offsets></xref><offsets xml_i="8022" xml_f="8024" txt_i="2831" txt_f="2833">].</offsets></p><p><offsets xml_i="8031" xml_f="8233" txt_i="2834" txt_f="3036">The number of elderly is rapidly growing. Almost a third of elderly subjects in the community with subthreshold depression or anxiety will develop a major depressive or anxiety disorder in three years [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="8264" xml_f="8265" txt_i="3036" txt_f="3037">8</offsets></xref><offsets xml_i="8272" xml_f="8362" txt_i="3037" txt_f="3127">]. Therefore, preventing the onset or development of these disorders has a high priority [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="8393" xml_f="8394" txt_i="3127" txt_f="3128">9</offsets></xref><offsets xml_i="8401" xml_f="8402" txt_i="3128" txt_f="3129">,</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="8434" xml_f="8436" txt_i="3129" txt_f="3131">10</offsets></xref><offsets xml_i="8443" xml_f="9108" txt_i="3131" txt_f="3796">]. Three types of prevention can be distinguished; universal prevention (aimed at the general population regardless of risk status), selective prevention (aimed at high-risk groups), and indicated prevention (aimed at subjects who have early symptoms of a disorder but do not meet diagnostic criteria). The aims of these types of preventive intervention are reduction of occurrence of new cases and the delay of onset of illness. Additionally, the aims of indicated preventive interventions might be to shorten the duration of the persistence of the early symptoms and to stop the progression of severity so that the subject does not meet DSM IV diagnostic levels [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="9140" xml_f="9142" txt_i="3796" txt_f="3798">11</offsets></xref><offsets xml_i="9149" xml_f="9290" txt_i="3798" txt_f="3939">]. Indicated prevention studies have shown that well designed interventions are capable of reducing the incidence of depression and anxiety [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="9322" xml_f="9324" txt_i="3939" txt_f="3941">12</offsets></xref><offsets xml_i="9331" xml_f="9415" txt_i="3941" txt_f="4025">]. Moreover, they are likely to be more cost-effective than alternative approaches [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="9447" xml_f="9449" txt_i="4025" txt_f="4027">13</offsets></xref><offsets xml_i="9456" xml_f="9675" txt_i="4027" txt_f="4246">]. So, favourable prevention should be well designed and should be aimed at selected groups of elderly, at high risk of developing anxiety or depression. Selected risk factors for the onset of late life depression are [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="9707" xml_f="9709" txt_i="4246" txt_f="4248">10</offsets></xref><offsets xml_i="9716" xml_f="9856" txt_i="4248" txt_f="4388">]: loss of a partner, chronic illness, neuroticism, family history, lack of social support and subthreshold anxiety or depression disorders.</offsets></p><p><offsets xml_i="9863" xml_f="10087" txt_i="4389" txt_f="4613">This project aims at the latter; the design and testing of a stepped care intervention to prevent the onset of full blown anxiety and depressive disorder among elderly people with subthreshold anxiety or depression disorder.</offsets></p><p><offsets xml_i="10094" xml_f="10147" txt_i="4614" txt_f="4667">The chosen intervention is a stepped care programme [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="10179" xml_f="10181" txt_i="4667" txt_f="4669">14</offsets></xref><offsets xml_i="10188" xml_f="10189" txt_i="4669" txt_f="4670">-</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="10221" xml_f="10223" txt_i="4670" txt_f="4672">16</offsets></xref><offsets xml_i="10230" xml_f="11186" txt_i="4672" txt_f="5628">]. In an environment of limited resources, it makes sense to provide expertise, and all the time and individual attention a patient needs, but not more. Stepped care models represent endeavours to maximize the effectiveness and efficiency of decisions about allocation of resources in therapy. Not all elderly with subthreshold anxiety or depression need the same type and intensity of preventive intervention. Frequently, complaints will disappear without active intervention. Some may be helped by reading a self-help book or watching an instructional video. Others could benefit from a brief psycho-educational group conducted by a paraprofessional or problem solving treatment, and still others may require a form of pharmacotherapy or more intensive individual psychological treatment. Although stepped care seems a logical approach from the clinical perspective, surprisingly few studies have actually examined the effects of stepped care programmes.</offsets></p><p><offsets xml_i="11193" xml_f="11854" txt_i="5629" txt_f="6290">The proposed generic stepped care programme is based on the following four assumptions: (a) empowerment; participants with subthreshold anxiety and depression need personalised, repeated education, counselling and confrontation with their symptom levels to be able to acknowledge them, (b) different persons require different levels of preventive activities; (c) determining the right level of preventive intervention is critically dependent on proactively monitoring outcome; and (d) stepping up from lower, less intensive to higher, more intensive levels of preventive activities based on monitored outcomes may increase effectiveness and lower costs overall.</offsets></p></sec><sec><title><offsets xml_i="11876" xml_f="11890" txt_i="6292" txt_f="6306">Methods/design</offsets></title><sec><title><offsets xml_i="11910" xml_f="11926" txt_i="6307" txt_f="6323">Aim of the study</offsets></title><p><offsets xml_i="11937" xml_f="12227" txt_i="6324" txt_f="6614">a) To put together an indicated prevention intervention for participants 75 years of age and over who live in the community and suffer from subthreshold anxiety or depression (but have no evidence of the clinical disorders) for use by home care in collaboration with mental health care, and</offsets></p><p><offsets xml_i="12234" xml_f="12376" txt_i="6615" txt_f="6757">b) To evaluate the effects of this programme versus usual general practitioner (GP) care in the prevention of depressive or anxiety disorders.</offsets></p></sec><sec><title><offsets xml_i="12398" xml_f="12410" txt_i="6759" txt_f="6771">Study design</offsets></title><p><offsets xml_i="12421" xml_f="12422" txt_i="6772" txt_f="6773">(</offsets><italic><offsets xml_i="12430" xml_f="12434" txt_i="6773" txt_f="6777">See </offsets></italic><offsets xml_i="12443" xml_f="12450" txt_i="6777" txt_f="6784">figure </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="12480" xml_f="12481" txt_i="6784" txt_f="6785">2</offsets></xref><offsets xml_i="12488" xml_f="12490" txt_i="6785" txt_f="6787">: </offsets><italic><offsets xml_i="12498" xml_f="12508" txt_i="6787" txt_f="6797">flow chart</offsets></italic><offsets xml_i="12517" xml_f="12729" txt_i="6797" txt_f="7009">) The study is a prospective randomised two-armed intervention study. Subjects are randomised by an independent statistician and assigned to intervention (stepped care programme) or control group (care as usual).</offsets></p></sec><sec><title><offsets xml_i="12751" xml_f="12763" txt_i="7011" txt_f="7023">Participants</offsets></title><p><offsets xml_i="12774" xml_f="13551" txt_i="7024" txt_f="7801">Adult persons, aged 75 years or older, with subthreshold anxiety or depression capable to give informed consent and with sufficient knowledge of the Dutch language are eligible. Subjects meeting criteria for major depression and/or clinical anxiety, subjects with insufficient mastery of the Dutch language and subjects unwilling or unable to give informed consent are excluded. A subject is defined to have subthreshold depression and/or anxiety when he or she scores above the cut-off score of 16 or more on the Centre for Epidemiologic Studies Depression scale (CES-D, a selfrating inventory for depression and/or anxiety), but does not meet criteria for a full-blown depressive or anxiety disorder as assessed with the Mini International Neuropsychiatric Interview (MINI) [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="13583" xml_f="13585" txt_i="7801" txt_f="7803">17</offsets></xref><offsets xml_i="13592" xml_f="13594" txt_i="7803" txt_f="7805">].</offsets></p></sec><sec><title><offsets xml_i="13616" xml_f="13627" txt_i="7807" txt_f="7818">Sample size</offsets></title><p><offsets xml_i="13638" xml_f="13857" txt_i="7819" txt_f="8038">Prospective data derived from the Longitudinal Ageing Study Amsterdam (LASA) study show that 27% of elderly subjects in the community with subthreshold depression develop a major depressive disorder within three years [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="13888" xml_f="13889" txt_i="8038" txt_f="8039">8</offsets></xref><offsets xml_i="13896" xml_f="14181" txt_i="8039" txt_f="8324">]. We assume that this percentage is comparable for subthreshold anxiety, and for combined anxiety and depression. The expected incidence rate of DSM-IV depressive or anxiety disorder within two years is estimated conservatively at 35%. Based on previous work in indicated prevention [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="14213" xml_f="14215" txt_i="8324" txt_f="8326">12</offsets></xref><offsets xml_i="14222" xml_f="14223" txt_i="8326" txt_f="8327">,</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="14255" xml_f="14257" txt_i="8327" txt_f="8329">18</offsets></xref><offsets xml_i="14264" xml_f="14698" txt_i="8329" txt_f="8763">], we expect the stepped care programme to reduce the incidence rate of major depression and/or anxiety disorder from 35% to 20%. We aim for 110 participants in each arm (Î± = 0.05 and a power of (1-Î²) = 0.80). If after final inclusion the total of participants unexpectedly falls short of the required number to reach a power of 0.8 in our calculations, pooling with the two other projects (see organisation chart) will be considered.</offsets></p></sec><sec><title><offsets xml_i="14720" xml_f="14731" txt_i="8765" txt_f="8776">Recruitment</offsets></title><p><offsets xml_i="14742" xml_f="14883" txt_i="8777" txt_f="8918">Eligible subjects for the present study are identified among the study population of the larger project for frail elderly -the PIKO project [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="14915" xml_f="14917" txt_i="8918" txt_f="8920">19</offsets></xref><offsets xml_i="14924" xml_f="15351" txt_i="8920" txt_f="9347">] in which this study is embedded. This PIKO project is based on the results of a self-rating health inventory, including the Centre for Epidemiologic Studies Depression scale (CES-D). The inventory has been completed by general practice patients of 75 years or older (see organisation chart). Subjects in this database with a CES-D score above the cut-off point of 16 are approached regarding compliance for the present study.</offsets></p></sec><sec><title><offsets xml_i="15373" xml_f="15411" txt_i="9349" txt_f="9387">Data collection/settings and locations</offsets></title><p><offsets xml_i="15422" xml_f="15553" txt_i="9388" txt_f="9519">The data are collected from subjects who live independently on their own in West-Friesland (North-Western part of the Netherlands).</offsets></p></sec><sec><title><offsets xml_i="15575" xml_f="15591" txt_i="9521" txt_f="9537">Outcome measures</offsets></title><p><offsets xml_i="15602" xml_f="15839" txt_i="9538" txt_f="9775">The primary outcome is the incidence of major depressive or anxiety (panic disorder, agoraphobia, social phobia and generalised anxiety) disorder (after two years) as measured with the Mini International Neuropsychiatric Interview (MINI)</offsets></p><p><offsets xml_i="15846" xml_f="15868" txt_i="9776" txt_f="9798">Secondary outcomes are</offsets></p><p><offsets xml_i="15875" xml_f="15965" txt_i="9799" txt_f="9889">-reduction of depressive and/or anxiety symptoms as measured with the CES-D and the HADS-A</offsets></p><p><offsets xml_i="15972" xml_f="16015" txt_i="9890" txt_f="9933">-improvement of quality of life (MOS-SF-36)</offsets></p><p><offsets xml_i="16022" xml_f="16032" txt_i="9934" txt_f="9944">-mortality</offsets></p></sec><sec><title><offsets xml_i="16054" xml_f="16065" txt_i="9946" txt_f="9957">Instruments</offsets></title><p><offsets xml_i="16076" xml_f="16178" txt_i="9958" txt_f="10060">The instruments used in this study are frequently applied in international studies and well validated.</offsets></p><sec><title><offsets xml_i="16194" xml_f="16221" txt_i="10061" txt_f="10088">MINI diagnostic interview [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="16253" xml_f="16255" txt_i="10088" txt_f="10090">17</offsets></xref><offsets xml_i="16262" xml_f="16263" txt_i="10090" txt_f="10091">,</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="16295" xml_f="16297" txt_i="10091" txt_f="10093">20</offsets></xref><offsets xml_i="16304" xml_f="16305" txt_i="10093" txt_f="10094">]</offsets></title><p><offsets xml_i="16316" xml_f="16773" txt_i="10095" txt_f="10552">The Mini International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview developed in 1990 by psychiatrists and clinicians in the United States and Europe for DSM-IV and ICD-10 psychiatric disorders. With an administration time of approximately 20 minutes, the MINI has become the structured interview of choice for psychiatric evaluation and outcome tracking in clinical psychopharmacology trials and epidemiological studies.</offsets></p><p><offsets xml_i="16780" xml_f="17287" txt_i="10553" txt_f="11060">The MINI interviews in this project entail the following modules: depressive disorder, dysthymia, panic disorder, agoraphobia, social phobia and generalized anxiety disorder. For this project we used MiniManager 2.0 (created by E.de Beurs, Leiden University Medical Centre), an electronic version of the Dutch MINI interview (5.0). Both the intervention and control participants will receive blinded independent assessments by telephone of depression and anxiety status at baseline, 6, 12, 18 and 24 months.</offsets></p></sec><sec><title><offsets xml_i="17309" xml_f="17316" txt_i="11062" txt_f="11069">CES-D [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="17348" xml_f="17350" txt_i="11069" txt_f="11071">21</offsets></xref><offsets xml_i="17357" xml_f="17358" txt_i="11071" txt_f="11072">-</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="17390" xml_f="17392" txt_i="11072" txt_f="11074">24</offsets></xref><offsets xml_i="17399" xml_f="17400" txt_i="11074" txt_f="11075">]</offsets></title><p><offsets xml_i="17411" xml_f="17822" txt_i="11076" txt_f="11487">The Centre for Epidemiologic Studies Depression scale (CES-D) will be used for the screening of subthreshold depression and anxiety. It consists of 20 items and its total score has a range between 0 and 60. Scores = 16 indicate clinically significant levels of depressive symptoms. At this cutoff the sensitivity is 100% and the specificity is 88% for major depressive disorder in the elderly Dutch population [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="17854" xml_f="17856" txt_i="11487" txt_f="11489">22</offsets></xref><offsets xml_i="17863" xml_f="17949" txt_i="11489" txt_f="11575">]. The CES-D has also been found to be a satisfactory screener for anxiety disorders [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="17981" xml_f="17983" txt_i="11575" txt_f="11577">23</offsets></xref><offsets xml_i="17990" xml_f="18318" txt_i="11577" txt_f="11905">]. However, as the CES-D was designed specifically for the screening of depression and as the criterion validity for depression was considerably better than for anxiety disorders, for follow-up purposes, the CES-D will be combined with additional items from the Hospital Anxiety and Depression scale â anxiety section (HADS-A) [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="18350" xml_f="18352" txt_i="11905" txt_f="11907">25</offsets></xref><offsets xml_i="18359" xml_f="18462" txt_i="11907" txt_f="12010">]. The aim is to optimise the sensitivity and specificity for both subthreshold depression and anxiety.</offsets></p></sec><sec><title><offsets xml_i="18484" xml_f="18490" txt_i="12012" txt_f="12018">HADS [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="18522" xml_f="18524" txt_i="12018" txt_f="12020">25</offsets></xref><offsets xml_i="18531" xml_f="18532" txt_i="12020" txt_f="12021">]</offsets></title><p><offsets xml_i="18543" xml_f="18927" txt_i="12022" txt_f="12406">The Hospital Anxiety and Depression Scale has been found to perform well in assessing the symptom severity and caseness of anxiety disorders and depression in both somatic, psychiatric and primary care patients and in the general population. Of the HADS, in this project only the seven anxiety items will be used to complement the anxiety-screening ability of the CES-D questionnaire.</offsets></p></sec><sec><title><offsets xml_i="18949" xml_f="18987" txt_i="12408" txt_f="12446">SF (Short Form) 36 â quality of life [</offsets><xref ref-type="bibr" rid="B26"><offsets xml_i="19019" xml_f="19021" txt_i="12446" txt_f="12448">26</offsets></xref><offsets xml_i="19028" xml_f="19029" txt_i="12448" txt_f="12449">]</offsets></title><p><offsets xml_i="19040" xml_f="19184" txt_i="12450" txt_f="12594">The SF36 is the short form questionnaire to measure quality of life. It was used in the original health inventory of the 'embedding' PIKO study.</offsets></p></sec><sec><title><offsets xml_i="19206" xml_f="19237" txt_i="12596" txt_f="12627">TiC-P health care utilisation [</offsets><xref ref-type="bibr" rid="B27"><offsets xml_i="19269" xml_f="19271" txt_i="12627" txt_f="12629">27</offsets></xref><offsets xml_i="19278" xml_f="19279" txt_i="12629" txt_f="12630">]</offsets></title><p><offsets xml_i="19290" xml_f="19551" txt_i="12631" txt_f="12892">Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P). This questionnaire will be applied to monitor costs. It is developed by the Trimbos Institute Utrecht in combination with the institute for Medical Technology Assessment Rotterdam</offsets></p></sec><sec><title><offsets xml_i="19573" xml_f="19657" txt_i="12894" txt_f="12978">Institution of Mental Health â thermometer (Geestelijke GezondheidsZorg thermometer)</offsets></title><p><offsets xml_i="19668" xml_f="19831" txt_i="12979" txt_f="13142">An instrument to measure patient treatment satisfaction. It focuses on the appreciation of treatment explanation, the social worker and the result of the coaching.</offsets></p><p><offsets xml_i="19838" xml_f="19844" txt_i="13143" txt_f="13149">table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="19876" xml_f="19877" txt_i="13149" txt_f="13150">1</offsets></xref><offsets xml_i="19884" xml_f="20000" txt_i="13150" txt_f="13266"> displays the outcome parameters, the above mentioned interview and instruments and additionally used questionnaires</offsets></p></sec></sec><sec><title><offsets xml_i="20028" xml_f="20039" txt_i="13269" txt_f="13280">Assessments</offsets></title><p><offsets xml_i="20050" xml_f="20269" txt_i="13281" txt_f="13500">Assessments take place at baseline (T0), start of the programme (T1), at three (T2), six (T3), nine (T4) and twelve months (T5) and then at eighteen = follow-up1 (T6) and twenty-four = follow-up2 (T7) months. See table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="20301" xml_f="20302" txt_i="13500" txt_f="13501">2</offsets></xref></p></sec><sec><title><offsets xml_i="20331" xml_f="20369" txt_i="13503" txt_f="13541">Intervention/the stepped care approach</offsets></title><p><offsets xml_i="20380" xml_f="20478" txt_i="13542" txt_f="13640">The stepped care approach in this project is based on several protocols with known effectiveness [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="20510" xml_f="20512" txt_i="13640" txt_f="13642">14</offsets></xref><offsets xml_i="20519" xml_f="20520" txt_i="13642" txt_f="13643">-</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="20552" xml_f="20554" txt_i="13643" txt_f="13645">16</offsets></xref><offsets xml_i="20561" xml_f="20892" txt_i="13645" txt_f="13976">] and discussions with the local homecare agency, regional mental health organisation and other careproviders such as GPs. Two interventions with a strong emphasis on psycho-education and the acquisition of skills with respect to the prevention of depression will be tested. First; the group course "Coping with Depression" (CWD) [</offsets><xref ref-type="bibr" rid="B28"><offsets xml_i="20924" xml_f="20926" txt_i="13976" txt_f="13978">28</offsets></xref><offsets xml_i="20933" xml_f="20934" txt_i="13978" txt_f="13979">,</offsets><xref ref-type="bibr" rid="B28"><offsets xml_i="20966" xml_f="20968" txt_i="13979" txt_f="13981">28</offsets></xref><offsets xml_i="20975" xml_f="20976" txt_i="13981" txt_f="13982">-</offsets><xref ref-type="bibr" rid="B30"><offsets xml_i="21008" xml_f="21010" txt_i="13982" txt_f="13984">30</offsets></xref><offsets xml_i="21017" xml_f="21228" txt_i="13984" txt_f="14195">] which is revised for anxiety and adapted for this specific population (75 years of age and older) and individual use and second; Problem Solving Treatment, which is a brief cognitive behavioral therapy (PST) [</offsets><xref ref-type="bibr" rid="B31"><offsets xml_i="21260" xml_f="21262" txt_i="14195" txt_f="14197">31</offsets></xref><offsets xml_i="21269" xml_f="21598" txt_i="14197" txt_f="14526">]. Both intervention protocols have come about in collaboration with the Trimbos Institute (the Netherlands) and the Mynors-Wallis (UK) group respectively. A valuable contribution to evidence-based treatments in the elderly might be constituted by the present study in the production of empirically supported treatment protocols.</offsets></p><p><offsets xml_i="21605" xml_f="21665" txt_i="14527" txt_f="14587">The stepped care programme as applied in this study entails:</offsets></p><p><italic><offsets xml_i="21680" xml_f="21823" txt_i="14588" txt_f="14731">Step 1: Elderly with subthreshold anxiety or depression are actively followed-up by watchful waiting whether participants recover spontaneously</offsets></italic><offsets xml_i="21832" xml_f="21833" txt_i="14731" txt_f="14732">.</offsets></p><p><offsets xml_i="21840" xml_f="22290" txt_i="14733" txt_f="15183">Subjects with a previously high CESD-score are invited to complete a second CESD questionnaire. The interval between the two CESD measurements is at least three months. In case of another score higher than the cut-off score, the MINI diagnostic interview takes place. When the result of the interview is negative (no symptoms of depressive/anxiety disorder during the past year) and the additional inclusion criteria are met, subjects are randomised.</offsets></p><p><italic><offsets xml_i="22305" xml_f="22535" txt_i="15184" txt_f="15414">Step 2, after randomisation. When spontaneous recovery does not occur, participants with subthreshold illness receive minimal interventions (folder, self-help book "Coping with Depression") This step is coached by home care nurses</offsets></italic><offsets xml_i="22544" xml_f="22545" txt_i="15414" txt_f="15415">.</offsets></p><p><offsets xml_i="22552" xml_f="23300" txt_i="15416" txt_f="16164">Subjects receive a telephone call with explanation about the intervention. After that, they receive the first questionnaire together with again -but this time; written- information. Shortly afterwards subjects are seen by a specially trained home care nurse who hands over a folder with information about and tips how to deal with subthreshold anxiety and/or depression. The aims of this first visit are: a) to assess type, the level of severity and causes of symptoms, b) to reflect on emotional symptoms through an initial brief nondirectional exploration and discussion of everyday problems, which also helps to establish a working relationship. c) to educate participants about their symptoms. The nurse makes an appointment for the next visit.</offsets></p><p><offsets xml_i="23307" xml_f="23947" txt_i="16165" txt_f="16805">During the second visit the folder will be briefly discussed and a reader, the self-help course "coping with depression" will be supplied to the client. Subjects are stimulated to do the course in their own tempo. The nurse will regularly ring or visit the client to discuss progress and questions. Obviously to read both folder and reader and make the exercises offered in the latter, is not obligatory. Subjects are free to read the information and make the exercises. An important aspect of the role of the nurse is advice and encouragement. After three months, at the end of the first phase an evaluation form is completed by the nurse.</offsets></p><p><offsets xml_i="23954" xml_f="24094" txt_i="16806" txt_f="16946">Step 3. When symptoms persist, participants are introduced to a brief cognitive behavioural therapy intervention (Problem Solving Treatment)</offsets></p><p><offsets xml_i="24101" xml_f="24519" txt_i="16947" txt_f="17365">If -after three months- there is still a CES-D score of 16 or higher, subjects will receive a telehone call in which is explained to them that they now qualify for Problem Solving Treatment. The method and approach are explained to them. The short-term Problem Solving Treatment is given by specially trained Community Psychiatric Nurses, who will also complete an evaluation form at the end of the maximum 7 sessions.</offsets></p><p><italic><offsets xml_i="24534" xml_f="24711" txt_i="17366" txt_f="17543">Step 4. At this final step, participants who still suffer from subthreshold depression or anxiety, are referred to their GP to discuss the appropriateness of specific medication</offsets></italic><offsets xml_i="24720" xml_f="24721" txt_i="17543" txt_f="17544">.</offsets></p><p><offsets xml_i="24728" xml_f="24882" txt_i="17545" txt_f="17699">In case of a continuously elevated CES-D score, subjects will receive written advice to discuss suitable medication with their GP (i.e., antidepressants).</offsets></p><p><offsets xml_i="24889" xml_f="25466" txt_i="17700" txt_f="18277">Summarising, the CES-D score is checked every three months during a year. Subjects with a result at or above the cut-off score of 16 are offered participation in the next step. A result below the cut-off score means; 'wait and see' for three months, after which a new evaluation takes place. At that point, again, a CES-D score of 16 or higher means that participation in the next step is offered after all. So, in the programme, postponement or cancellation of steps is possible. When a major depression or an anxiety disorder develops, subjects are referred back to their GP.</offsets></p></sec></sec><sec><title><offsets xml_i="25494" xml_f="25504" txt_i="18280" txt_f="18290">Discussion</offsets></title><p><offsets xml_i="25515" xml_f="25684" txt_i="18291" txt_f="18460">Late-life depression and anxiety are characterised by high prevalence, unfavourable prognosis, reduced quality of life, excess mortality and substantial societal costs [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="25716" xml_f="25718" txt_i="18460" txt_f="18462">13</offsets></xref><offsets xml_i="25725" xml_f="25846" txt_i="18462" txt_f="18583">]. Fortunately, there are hopeful indications that the prevention of new cases of mental disorders seems to be possible [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="25878" xml_f="25880" txt_i="18583" txt_f="18585">12</offsets></xref><offsets xml_i="25887" xml_f="26104" txt_i="18585" txt_f="18802">]. Subthreshold anxiety and depression (i.e., the presence of symptoms of anxiety or depression without evidence of the actual psychiatric disorder) are prognostic variables for major anxiety disorder and depression [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="26136" xml_f="26138" txt_i="18802" txt_f="18804">13</offsets></xref><offsets xml_i="26145" xml_f="26269" txt_i="18804" txt_f="18928">]. Interventions in the subthreshold disorders may prevent the onset of new cases of major depression and anxiety disorder [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="26301" xml_f="26303" txt_i="18928" txt_f="18930">18</offsets></xref><offsets xml_i="26310" xml_f="26587" txt_i="18930" txt_f="19207">]. Demonstration projects of shared care models for indicated prevention of new cases of mental disorders may be an important step forward to reduce the enormous burden of these disorders as was shown by a recent meta-analysis of randomised trials of preventive interventions [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="26619" xml_f="26621" txt_i="19207" txt_f="19209">12</offsets></xref><offsets xml_i="26628" xml_f="26894" txt_i="19209" txt_f="19475">] In this study the indicated prevention of depression and anxiety is attempted by way of a stepped-care programme offering the aged subthreshold depressed or anxious participant, several interventions ranging from noncommittal to the requirement of some engagement.</offsets></p><p><offsets xml_i="26901" xml_f="26973" txt_i="19476" txt_f="19548">A preliminary reflection on the limitations and strengths of our design:</offsets></p><p><offsets xml_i="26980" xml_f="27490" txt_i="19549" txt_f="20059">A limitation of this pragmatic design is that it will be difficult to weigh the specific contributions of the various elements of this project. Another limitation may be that the quantity and type of questions (questions about mood may be confronting and depressing on their own) can lead to drop-out. The stimulating ideas and activities in the self-help course trying to achieve a positive and active attitude may have an opposite effect since the reader might instead be confronted with his/her limitations.</offsets></p><p><offsets xml_i="27497" xml_f="27527" txt_i="20060" txt_f="20090">Strong aspects of this design:</offsets></p><p><offsets xml_i="27534" xml_f="27743" txt_i="20091" txt_f="20300">- It is a unique practice-based project in which several evidence-based aspects of for instance the highly successful IMPACT treatment study (Improving Mood: Promoting Access to Collaborative Care Treatment) [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="27775" xml_f="27777" txt_i="20300" txt_f="20302">16</offsets></xref><offsets xml_i="27784" xml_f="28363" txt_i="20302" txt_f="20881">] are incorporated, now for indicated prevention purposes and among a very old population. Where IMPACT provides its participants of 60 years of age or older with education, brief psychotherapy, medication and stepped care while outcomes and progress are regularly and closely monitored by a care manager, in this Dutch project the participants are older but very similar items compared to the IMPACT model are employed. However, the focus now is on symptoms and on indicated prevention, not on treatment of persons who drew up a specific treatment contract with their physician.</offsets></p><p><offsets xml_i="28370" xml_f="28525" txt_i="20882" txt_f="21037">- A further strength of our study is that it encompasses anxiety: that even less studies among the elderly have looked at indicated prevention of anxiety [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="28557" xml_f="28559" txt_i="21037" txt_f="21039">12</offsets></xref><offsets xml_i="28566" xml_f="28567" txt_i="21039" txt_f="21040">,</offsets><xref ref-type="bibr" rid="B32"><offsets xml_i="28599" xml_f="28601" txt_i="21040" txt_f="21042">32</offsets></xref><offsets xml_i="28608" xml_f="28658" txt_i="21042" txt_f="21092">], and at co-morbidity of anxiety and depression [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="28690" xml_f="28692" txt_i="21092" txt_f="21094">12</offsets></xref><offsets xml_i="28699" xml_f="28815" txt_i="21094" txt_f="21210">]. There are several community studies which show that anxiety is as important a problem for elderly as depression [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="28846" xml_f="28847" txt_i="21210" txt_f="21211">2</offsets></xref><offsets xml_i="28854" xml_f="28855" txt_i="21211" txt_f="21212">,</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="28886" xml_f="28887" txt_i="21212" txt_f="21213">3</offsets></xref><offsets xml_i="28894" xml_f="28896" txt_i="21213" txt_f="21215">].</offsets></p><p><offsets xml_i="28903" xml_f="29505" txt_i="21216" txt_f="21818">The third strength is that we will also be able to reflect on the ethical dilemma of whether or not to include persons in programmes such as these who are at risk (i.e., not participants) but have no explicit request for care. The percentage uptake of the intervention in the various stepped care stages and the participants' preferences will show us whether an intervention aimed at symptoms and not at syndromes connects to the reality of distressed old people in the community. The questions would be whether these elderly are willing to acknowledge distress and to take active steps to feel better.</offsets></p><p><offsets xml_i="29512" xml_f="29735" txt_i="21819" txt_f="22042">Strengths and limitations taken into account, the development and research of (cost) effective means to prevent depressive and anxiety disorder in the rapidly growing group of elderly is a matter of the greatest importance.</offsets></p><sec><title><offsets xml_i="29751" xml_f="29773" txt_i="22043" txt_f="22065">Timeframe of the study</offsets></title><p><offsets xml_i="29784" xml_f="29794" txt_i="22066" txt_f="22076">See table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="29826" xml_f="29827" txt_i="22076" txt_f="22077">2</offsets></xref></p></sec><sec><title><offsets xml_i="29856" xml_f="29876" txt_i="22079" txt_f="22099">Description of risks</offsets></title><p><offsets xml_i="29887" xml_f="30055" txt_i="22100" txt_f="22268">To our knowledge, serious risks or undesired effects of completing questionnaires are not reported in the literature. There are no specific risks related to this study.</offsets></p></sec><sec><title><offsets xml_i="30077" xml_f="30095" txt_i="22270" txt_f="22288">Ethical principles</offsets></title><p><offsets xml_i="30106" xml_f="30346" txt_i="22289" txt_f="22529">The participation in the study is voluntarily. Participants are informed that they can cancel their participation at any time without disclosing reasons for their cancellation and without negative consequences for their future medical care.</offsets></p></sec><sec><title><offsets xml_i="30368" xml_f="30396" txt_i="22531" txt_f="22559">Vote of the ethics committee</offsets></title><p><offsets xml_i="30407" xml_f="30523" txt_i="22560" txt_f="22676">The design and conduct of the study was approved by the ethics committee of VU University Medical Centre, Amsterdam.</offsets></p></sec><sec><title><offsets xml_i="30545" xml_f="30558" txt_i="22678" txt_f="22691">Data security</offsets></title><p><offsets xml_i="30569" xml_f="30810" txt_i="22692" txt_f="22933">Confidential information and participant names are secured by the medical confidentiality rules and are treated according to the code of conduct for medical research, developed by the FMWV (the Federation of Biomedical Scientific Societies).</offsets></p><p></p></sec></sec><sec><title><offsets xml_i="30845" xml_f="30864" txt_i="22937" txt_f="22956">Competing interests</offsets></title><p><offsets xml_i="30875" xml_f="30935" txt_i="22957" txt_f="23017">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="30957" xml_f="30979" txt_i="23019" txt_f="23041">Authors' contributions</offsets></title><p><offsets xml_i="30990" xml_f="31022" txt_i="23042" txt_f="23074">NvtV, HvM, PvO perform the study</offsets></p><p><offsets xml_i="31029" xml_f="31103" txt_i="23075" txt_f="23149">HvM participated in the draft manuscript of the proposal, the study design</offsets></p><p><offsets xml_i="31110" xml_f="31189" txt_i="23150" txt_f="23229">AB and PC participated in the draft manuscript and the conceiving of this study</offsets></p><p><offsets xml_i="31196" xml_f="31280" txt_i="23230" txt_f="23314">GN and HvH provided the setting and the coordination of the 'embedding' project PIKO</offsets></p><p><offsets xml_i="31287" xml_f="31340" txt_i="23315" txt_f="23368">AB and WS are responsible for the overall supervision</offsets></p><p><offsets xml_i="31347" xml_f="31397" txt_i="23369" txt_f="23419">All authors read and approved the final manuscript</offsets></p></sec><sec><title><offsets xml_i="31419" xml_f="31442" txt_i="23421" txt_f="23444">Pre-publication history</offsets></title><p><offsets xml_i="31453" xml_f="31517" txt_i="23445" txt_f="23509">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2458/6/186/prepub"></ext-link></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This study is financed by ZonMw â the Netherlands Organisation for Health Research and Development, grant-number 2620.00003</p><p>Edwin de Beurs gave permission to use MiniManager, his electronic version of the Dutch MINI diagnostic interview.</p><p>The group course "Coping with Depression" (CWD) was revised for anxiety and adapted for 75+ readers and individual use by the Trimbos Institute.</p><p>The Problem Solving Treatment training was given and supervised by Mrs. I. Davies BSc RGN/RMN</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>de Beurs</surname><given-names>E</given-names></name><name><surname>van Balkom</surname><given-names>AJ</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>van Dyck</surname><given-names>R</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>Anxiety and depression in later life: Co-occurrence and communality of risk factors</article-title><source>Am J Psychiatry</source><year>2000</year><volume>157</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">10618018</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Hout</surname><given-names>HP</given-names></name><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>de Beurs</surname><given-names>E</given-names></name><name><surname>Comijs</surname><given-names>H</given-names></name><name><surname>van Marwijk</surname><given-names>H</given-names></name><name><surname>de Haan</surname><given-names>M</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name></person-group><article-title>Anxiety and the risk of death in older men and women</article-title><source>Br J Psychiatry</source><year>2004</year><volume>185</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">15516548</pub-id><pub-id pub-id-type="doi">10.1192/bjp.185.5.399</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Beurs</surname><given-names>E</given-names></name><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>van Balkom</surname><given-names>AJ</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>van Dyck</surname><given-names>R</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>Consequences of anxiety in older persons: its effect on disability, well-being and use of health services</article-title><source>Psychol Med</source><year>1999</year><volume>29</volume><fpage>583</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">10405079</pub-id><pub-id pub-id-type="doi">10.1017/S0033291799008351</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schoevers</surname><given-names>RA</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name><name><surname>Beekman</surname><given-names>AT</given-names></name></person-group><article-title>Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients</article-title><source>Am J Geriatr Psychiatry</source><year>2005</year><volume>13</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">15653938</pub-id><pub-id pub-id-type="doi">10.1176/appi.ajgp.13.1.31</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>de Beurs</surname><given-names>E</given-names></name><name><surname>Geerling</surname><given-names>SW</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>The impact of depression on the well-being, disability and use of services in older adults: a longitudinal perspective</article-title><source>Acta Psychiatr Scand</source><year>2002</year><volume>105</volume><fpage>20</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12086221</pub-id><pub-id pub-id-type="doi">10.1034/j.1600-0447.2002.10078.x</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katon</surname><given-names>WJ</given-names></name><name><surname>Lin</surname><given-names>E</given-names></name><name><surname>Russo</surname><given-names>J</given-names></name><name><surname>Unutzer</surname><given-names>J</given-names></name></person-group><article-title>Increased medical costs of a population-based sample of depressed elderly patients</article-title><source>Arch Gen Psychiatry</source><year>2003</year><volume>60</volume><fpage>897</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">12963671</pub-id><pub-id pub-id-type="doi">10.1001/archpsyc.60.9.897</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name></person-group><article-title>Mortality and depressive symptoms in inhabitants of residential homes</article-title><source>Int J Geriatr Psychiatry</source><year>2001</year><volume>16</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">11241717</pub-id><pub-id pub-id-type="doi">10.1002/1099-1166(200102)16:2&lt;131::AID-GPS283&gt;3.0.CO;2-W</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>Geerlings</surname><given-names>SW</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Schoevers</surname><given-names>RS</given-names></name><name><surname>de Beurs</surname><given-names>E</given-names></name><name><surname>Braam</surname><given-names>AW</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>The natural history of late-life depression: a 6-year prospective study in the community</article-title><source>Arch Gen Psychiatry</source><year>2002</year><volume>59</volume><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">12090813</pub-id><pub-id pub-id-type="doi">10.1001/archpsyc.59.7.605</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>Geerlings</surname><given-names>SW</given-names></name><name><surname>Schoevers</surname><given-names>RA</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>Emergence and persistence of late life depression: a 3-year follow-up of the Longitudinal Aging Study Amsterdam</article-title><source>J Affect Disord</source><year>2001</year><volume>65</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">11356236</pub-id><pub-id pub-id-type="doi">10.1016/S0165-0327(00)00243-3</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Beurs</surname><given-names>E</given-names></name><name><surname>Beekman</surname><given-names>A</given-names></name><name><surname>Geerlings</surname><given-names>S</given-names></name><name><surname>Deeg</surname><given-names>D</given-names></name><name><surname>van Dyck</surname><given-names>R</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>On becoming depressed or anxious in late life: similar vulnerability factors but different effects of stressful life events</article-title><source>Br J Psychiatry</source><year>2001</year><volume>179</volume><fpage>426</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">11689400</pub-id><pub-id pub-id-type="doi">10.1192/bjp.179.5.426</pub-id></citation></ref><ref id="B11"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Haggerty</surname><given-names>M</given-names></name><name><surname>Medicine</surname><given-names>I</given-names></name></person-group><source>Reducing risks for mental disorders</source><year>1994</year><publisher-name>Washinton DC, National Academy Press</publisher-name></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Van Straten</surname><given-names>A</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name></person-group><article-title>Preventing the incidence of new cases of mental disorders: a meta-analytic review</article-title><source>J Nerv Ment Dis</source><year>2005</year><volume>193</volume><fpage>119</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">15684914</pub-id><pub-id pub-id-type="doi">10.1097/01.nmd.0000152810.76190.a6</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>F</given-names></name><name><surname>Ederveen</surname><given-names>A</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Deeg</surname><given-names>D</given-names></name><name><surname>Beekman</surname><given-names>A</given-names></name></person-group><article-title>Opportunities for Cost-effective Prevention of Late-Life Depression: An Epidemiological Approach</article-title><source>Arch Gen Psychiatry</source><year>2006</year><volume>63</volume><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">16520434</pub-id><pub-id pub-id-type="doi">10.1001/archpsyc.63.3.290</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>MW</given-names></name><name><surname>Pollack</surname><given-names>MH</given-names></name><name><surname>Maki</surname><given-names>KM</given-names></name></person-group><article-title>Empirically supported treatments for panic disorder: costs, benefits, and stepped care</article-title><source>J Consult Clin Psychol</source><year>2000</year><volume>68</volume><fpage>556</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">10965630</pub-id><pub-id pub-id-type="doi">10.1037/0022-006X.68.4.556</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haaga</surname><given-names>DA</given-names></name></person-group><article-title>Introduction to the special section on stepped care models in psychotherapy</article-title><source>J Consult Clin Psychol</source><year>2000</year><volume>68</volume><fpage>547</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">10965628</pub-id><pub-id pub-id-type="doi">10.1037/0022-006X.68.4.547</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunkeler</surname><given-names>EM</given-names></name><name><surname>Katon</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>JWJ</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>EH</given-names></name><name><surname>Harpole</surname><given-names>LH</given-names></name><name><surname>Arean</surname><given-names>P</given-names></name><name><surname>Levine</surname><given-names>S</given-names></name><name><surname>Grypma</surname><given-names>LM</given-names></name><name><surname>Hargreaves</surname><given-names>WA</given-names></name><name><surname>Unutzer</surname><given-names>J</given-names></name></person-group><article-title>Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care</article-title><source>BMJ</source><year>2006</year><volume>332</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">16428253</pub-id><pub-id pub-id-type="doi">10.1136/bmj.38683.710255.BE</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV</given-names></name><name><surname>Lecrubier</surname><given-names>Y</given-names></name><name><surname>Sheehan</surname><given-names>KH</given-names></name><name><surname>Amorim</surname><given-names>P</given-names></name><name><surname>Janavs</surname><given-names>J</given-names></name><name><surname>Weiller</surname><given-names>E</given-names></name><name><surname>Hergueta</surname><given-names>T</given-names></name><name><surname>Baker</surname><given-names>R</given-names></name><name><surname>Dunbar</surname><given-names>GC</given-names></name></person-group><article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title><source>J Clin Psychiatry</source><year>1998</year><volume>59 Suppl 20</volume><fpage>22</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9881538</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willemse</surname><given-names>GR</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Tiemens</surname><given-names>BG</given-names></name></person-group><article-title>Minimal-contact psychotherapy for sub-threshold depression in primary care. Randomised trial</article-title><source>Br J Psychiatry</source><year>2004</year><volume>185</volume><fpage>416</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">15516551</pub-id><pub-id pub-id-type="doi">10.1192/bjp.185.5.416</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Hout</surname><given-names>HP</given-names></name><name><surname>Nijpels</surname><given-names>G</given-names></name><name><surname>van Marwijk</surname><given-names>HW</given-names></name><name><surname>Jansen</surname><given-names>AP</given-names></name><name><surname>Van't Veer</surname><given-names>PJ</given-names></name><name><surname>Tybout</surname><given-names>W</given-names></name><name><surname>Stalman</surname><given-names>WA</given-names></name></person-group><article-title>Design and pilot results of a single blind randomized controlled trial of systematic demand-led home visits by nurses to frail elderly persons in primary care [ISRCTN05358495]</article-title><source>BMC Geriatr</source><year>2005</year><volume>5</volume><fpage>11</fpage><pub-id pub-id-type="pmid">16150147</pub-id><pub-id pub-id-type="doi">10.1186/1471-2318-5-11</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinninti</surname><given-names>NR</given-names></name><name><surname>Madison</surname><given-names>H</given-names></name><name><surname>Musser</surname><given-names>E</given-names></name><name><surname>Rissmiller</surname><given-names>D</given-names></name></person-group><article-title>MINI International Neuropsychiatric Schedule: clinical utility and patient acceptance</article-title><source>Eur Psychiatry</source><year>2003</year><volume>18</volume><fpage>361</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">14643565</pub-id><pub-id pub-id-type="doi">10.1016/j.eurpsy.2003.03.004</pub-id></citation></ref><ref id="B21"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Radloff</surname><given-names>LS</given-names></name></person-group><article-title>The CES-D Scale: a self-report depression scale for research in the general population.</article-title><source>J Applied Psychol Measurement</source><year>1977</year><fpage>385</fpage><lpage>401</lpage></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>Van Limbeek</surname><given-names>J</given-names></name><name><surname>Braam</surname><given-names>AW</given-names></name><name><surname>De Vries</surname><given-names>MZ</given-names></name><name><surname>van Tilburg</surname><given-names>W</given-names></name></person-group><article-title>Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands</article-title><source>Psychol Med</source><year>1997</year><volume>27</volume><fpage>231</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">9122304</pub-id><pub-id pub-id-type="doi">10.1017/S0033291796003510</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breslau</surname><given-names>N</given-names></name></person-group><article-title>Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews</article-title><source>Psychiatry Res</source><year>1985</year><volume>15</volume><fpage>219</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">3862157</pub-id><pub-id pub-id-type="doi">10.1016/0165-1781(85)90079-4</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radloff</surname><given-names>LS</given-names></name><name><surname>Teri</surname><given-names>L</given-names></name></person-group><article-title>Use of the Center for Epidemiological Studies-Depression Scale with older adults.</article-title><source>Clinical Gerontologist</source><year>1986</year><volume>5</volume><fpage>119</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1300/J018v05n01_06</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zigmond</surname><given-names>AS</given-names></name><name><surname>Snaith</surname><given-names>RP</given-names></name></person-group><article-title>The hospital anxiety and depression scale</article-title><source>Acta Psychiatr Scand</source><year>1983</year><volume>67</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">6880820</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>JJ</given-names></name><name><surname>Sherbourne</surname><given-names>CD</given-names></name></person-group><article-title>The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.</article-title><source>Medical Care</source><year>1992</year><fpage>473</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">1593914</pub-id></citation></ref><ref id="B27"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Hakkaart-van Roijen</surname><given-names>L</given-names></name><name><surname>Van Straten</surname><given-names>A</given-names></name><name><surname>Donker</surname><given-names>M</given-names></name><name><surname>Tiemens</surname><given-names>B</given-names></name></person-group><article-title>Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P)</article-title><year>2002</year></citation></ref><ref id="B28"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Lewinsohn</surname><given-names>PM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Eugene ORCP</surname></name></person-group><source>The Coping with Depression course: A psychoeducational intervention for unipolar depression</source><year>1984</year></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name></person-group><article-title>Bibliotherapy in unipolar depression: a meta-analysis</article-title><source>J Behav Ther Exp Psychiatry</source><year>1997</year><volume>28</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">9194011</pub-id><pub-id pub-id-type="doi">10.1016/S0005-7916(97)00005-0</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haringsma</surname><given-names>R</given-names></name><name><surname>Engels</surname><given-names>GI</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name><name><surname>Spinhoven</surname><given-names>P</given-names></name></person-group><article-title>Effectiveness of the Coping With Depression (CWD) course for older adults provided by the community-based mental health care system in the Netherlands: a randomized controlled field trial</article-title><source>Int Psychogeriatr</source><year>2005</year><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">15945587</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mynors-Wallis</surname><given-names>L</given-names></name><name><surname>Davies</surname><given-names>I</given-names></name><name><surname>Gray</surname><given-names>A</given-names></name><name><surname>Barbour</surname><given-names>F</given-names></name><name><surname>Gath</surname><given-names>D</given-names></name></person-group><article-title>A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care</article-title><source>Br J Psychiatry</source><year>1997</year><volume>170</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">9093498</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuijpers</surname><given-names>P</given-names></name></person-group><article-title>Examining the effects of prevention programs on the incidence of new cases of mental disorders: the lack of statistical power</article-title><source>Am J Psychiatry</source><year>2003</year><volume>160</volume><fpage>1385</fpage><lpage>1391</lpage><pub-id pub-id-type="pmid">12900296</pub-id><pub-id pub-id-type="doi">10.1176/appi.ajp.160.8.1385</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Organisation chart</p></caption><graphic xlink:href="1471-2458-6-186-1"></graphic></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Flowchart</p></caption><graphic xlink:href="1471-2458-6-186-2"></graphic></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Instruments used to establish primary and secondary outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Outcome measures</bold></td><td align="left"><bold>Instrument</bold></td></tr></thead><tbody><tr><td align="left"><bold>Primary outcome</bold></td><td></td></tr><tr><td align="left">depressive/anxiety disorder</td><td align="left">MINI diagnostic interview</td></tr><tr><td align="left"><bold>Secondary outcome</bold></td><td></td></tr><tr><td align="left">reduction of depressive symptoms</td><td align="left">CES-D</td></tr><tr><td align="left">reduction of anxiety symptoms</td><td align="left">HADS-A</td></tr><tr><td align="left">quality of life</td><td align="left">MOS-SF-36</td></tr><tr><td align="left">health care utilisation</td><td align="left">TIC-P</td></tr><tr><td align="left">patient satisfaction</td><td align="left">GGZ thermometer</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Assessments</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><bold><underline>health inventory</underline> T0</bold></td><td align="center"><bold>T1-a</bold></td><td align="center"><bold>T1-b</bold></td><td align="center"><bold>T1-c</bold></td><td align="center"><bold>T2 </bold>3 mnths</td><td align="center"><bold>T3 </bold>6 mnths</td><td align="center"><bold>T4 </bold>9 mnths</td><td align="center"><bold>T5 </bold>12 mnths</td><td align="center"><bold>T6 </bold>18 mnths</td><td align="center"><bold>T7 </bold>24 mnths</td></tr></thead><tbody><tr><td align="left"><bold>CES-D</bold></td><td align="center">x</td><td align="center">x</td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">x</td><td align="center">x</td><td align="center">x</td><td align="center">x</td><td align="center">x</td></tr><tr><td align="left"><bold>MINI</bold></td><td></td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">x</td><td align="center">x</td><td align="center">x</td></tr><tr><td align="left"><bold>extra identification information</bold></td><td></td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="left"><bold>HADS-A</bold></td><td></td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">x</td><td align="center">x</td><td align="center">x</td></tr><tr><td align="left"><bold>SF36</bold></td><td></td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">x</td></tr><tr><td align="left"><bold>TIC-P health care utilisation</bold></td><td></td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">x</td><td align="center">-</td><td align="center">x</td><td align="center">x</td><td align="center">x</td></tr><tr><td align="left"><bold>pt.satisfaction</bold></td><td></td><td align="center">-</td><td align="center">-</td><td align="center">x</td><td align="center">x</td><td align="center">x</td><td align="center">x</td><td align="center">x</td><td align="center">x</td><td align="center">x</td></tr></tbody></table></table-wrap></sec></back></article>